SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neptune Technologies & Bioressources Inc. - NTB.V
An SI Board Since July 2011
Posts SubjectMarks Bans Symbol
902 9 0 NEPT
Emcee:  Sultan Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
77Neptune Announces Dividend-in-Kind and Record Date for Partial Spin-Off of NeuroSultan19/7/2012
76Roth Capital Reiterates Buy On Heels Of Strong Neptune Response To Competitor’s Sultan19/6/2012
75Neptune's Competitor Claims an Illusory Victory [graphic]Press Release: NepSultan-9/6/2012
74The Story of Krill Oil.. jamiesonvitamins.comSultan-8/24/2012
73Chen Lin's Key to Huge Biotech Profits: Make It Personal thelifesciencesrepSultan18/24/2012
72Burrill & Company Initiates Coverage On Neptune - Sets A $7 Price Target Sultan18/21/2012
71Think Long Term and Win Big with Small Biotechs: Hugh Cleland By The Life ScSultan18/10/2012
70No worries!!The Ox-8/2/2012
69Oops.. Posted MRGE on NEPT board.. lol.. Sultan-8/1/2012
68Merge Healthcare's CEO Discusses Q2 2012 Results - Earnings Call Transcript Sultan-8/1/2012
67Missed the actual source of the previous post.. Here it is.. biomedreports.comSultan-7/27/2012
66Roth Capital Says Amarin's Approval Provides Visibility for Neptune ReiteratSultan-7/27/2012
65Amarin’s FDA Approval! Will it Positively Impact Neptune & Acasti ValuationsSultan-7/26/2012
64Wednesday, 18 July, 2012 Catalyst Equity Research Ups Strong Buy Target to $9.Sultan17/18/2012
63Neptune Reports First Quarter Results Nutraceutical Quarterly Revenues IncreaseSultan17/16/2012
62Ok.. Will have to keep an eye.. My main concern is their plant expansion.. HopeSultan-7/13/2012
61My biggest concern for NEPT is their growing SG+A as a percentage of revenue. ThThe Ox-7/13/2012
60Agree with you.. I have been in biotechs and have been burned before.. What isSultan-7/13/2012
59One caution on stocks that soar on phase II studies releases. It may take a longThe Ox-7/13/2012
58IR commentary today.. Neptune Article – “Trading The Top Triglyceride ChallengeSultan17/13/2012
57Acasti Pharma to Present at JMP Securities Healthcare Conference LAVAL, QuebecSultan17/9/2012
56I am happy to see them here.. Hopefully, it gets over 5+ soon enough.. Long termSultan-6/29/2012
554 Year high!The Ox-6/29/2012
54Additional Clarification - Neptune - NeuroBioPharm Dividend In our commentary Sultan-6/28/2012
53Neurobiopharm Dividend - Neptune Files Preliminary Prospectus While a news relSultan-6/28/2012
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News